244 related articles for article (PubMed ID: 21628490)
1. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
De Angelis G; Cipriani M; Cauda R; Tacconelli E
Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490
[No Abstract] [Full Text] [Related]
2. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Hyun DY; Mason EO; Forbes A; Kaplan SL
Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
[TBL] [Abstract][Full Text] [Related]
3. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Whitman TJ
Dis Mon; 2008 Dec; 54(12):780-6. PubMed ID: 18996280
[No Abstract] [Full Text] [Related]
4. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
5. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.
Esposito S; Leone S; Petta E; Noviello S; Ianniello F
Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S30-5. PubMed ID: 19560673
[TBL] [Abstract][Full Text] [Related]
7. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
Pichereau S; Rose WE
Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy.
Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW
Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483
[TBL] [Abstract][Full Text] [Related]
9. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
Cunha BA
Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
Frei CR; Miller ML; Lewis JS; Lawson KA; Hunter JM; Oramasionwu CU; Talbert RL
J Am Board Fam Med; 2010; 23(6):714-9. PubMed ID: 21057066
[TBL] [Abstract][Full Text] [Related]
11. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.
Pangilinan R; Tice A; Tillotson G
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):957-65. PubMed ID: 19803705
[TBL] [Abstract][Full Text] [Related]
12. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children.
Teng CS; Lo WT; Wang SR; Tseng MH; Chu ML; Wang CC
J Microbiol Immunol Infect; 2009 Aug; 42(4):324-8. PubMed ID: 19949756
[TBL] [Abstract][Full Text] [Related]
13. Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK.
Enoch DA; Karas JA; Aliyu SH
Int J Antimicrob Agents; 2009 Jun; 33(6):497-502. PubMed ID: 19101123
[TBL] [Abstract][Full Text] [Related]
14. Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline.
Curcio D
Clin Infect Dis; 2011 Jun; 52(12):1468-9. PubMed ID: 21498390
[No Abstract] [Full Text] [Related]
15. An alternative to open incision and drainage for community-acquired soft tissue abscesses in children.
McNamara WF; Hartin CW; Escobar MA; Yamout SZ; Lau ST; Lee YH
J Pediatr Surg; 2011 Mar; 46(3):502-6. PubMed ID: 21376200
[TBL] [Abstract][Full Text] [Related]
16. Predictors of community-acquired methicillin resistant Staphylococcus aureus in the inpatient population.
Bulchandani D; Comes I; Nachnani J; Al-Hihi E; Bix J; Foxworth J
Mo Med; 2008; 105(6):510-3. PubMed ID: 19052013
[TBL] [Abstract][Full Text] [Related]
17. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children.
Frei CR; Makos BR; Daniels KR; Oramasionwu CU
J Pediatr Surg; 2010 Oct; 45(10):1967-74. PubMed ID: 20920714
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for complicated skin and skin-structure infections.
Mendoza N; Tyring SK
Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
[TBL] [Abstract][Full Text] [Related]
19. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
Fergie J; Purcell K
Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
[No Abstract] [Full Text] [Related]
20. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients.
Trinh TT; Short WR; Mermel LA
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):176-80. PubMed ID: 19423878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
